ログイン
Language:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. Public
  2. 研究紀要
  3. ACTA MEDICA KINDAI UNIVERSITY
  4. 50(2)2025

Integrin alpha subunit 2 (ITGA2) enhances cisplatin resistance in osteosarcoma

https://doi.org/10.15100/0002003779
https://doi.org/10.15100/0002003779
8282c94d-c65a-47cc-aca9-d1034317907f
名前 / ファイル ライセンス アクション
AA0050842X-20251200-0021.pdf AA0050842X-20251200-0021.pdf (2.0 MB)
アイテムタイプ 紀要論文 / departmental bulletin paper(1)
公開日 2025-12-22
タイトル
タイトル Integrin alpha subunit 2 (ITGA2) enhances cisplatin resistance in osteosarcoma
言語 en
作成者 Ito, Tomohiko

× Ito, Tomohiko

en Ito, Tomohiko
Kindai University

Search repository
Oka, Naohiro

× Oka, Naohiro

en Oka, Naohiro
Kindai University

Search repository
Hashimoto, Kazuhiko

× Hashimoto, Kazuhiko

en Hashimoto, Kazuhiko
Kindai University

Search repository
Nishimura, Shunji

× Nishimura, Shunji

en Nishimura, Shunji
Kindai University

Search repository
Akagi, Masao

× Akagi, Masao

en Akagi, Masao
Kindai University

Search repository
Goto, Kouji

× Goto, Kouji

en Goto, Kouji
Kindai University

Search repository
言語
言語 eng
キーワード
主題 Osteosarcoma, chemoresistance, cisplatin-resistant, ITGA2 (integrin alpha subunit 2)
内容記述
内容記述タイプ Abstract
内容記述 Osteosarcoma (OS) is the leading cause of cancerrelated deaths in children and adolescents. Current standard treatment strategies, which combine chemotherapy and surgical resection, have significantly improved 5-year survival rates. However, overall survival rate has not dramatically improved over the past few decades. One of the critical factors affecting the overall survival of patients with OS is chemoresistance, either present in the primary tumor or acquired during chemotherapy. In the present study, we established cisplatin-resistant OS cell lines with continuous exposure to cisplatin and observed dysregulated wound healing signaling. Among the genes responsible for wound healing, we focused on ITGA2 (integrin alpha subunit 2), and found that ITGA2 was a critical determinant of cisplatin sensitivity in the OS cells in vivo. Depletion of ITGA2 in cisplatin-resistant OS cells restored cisplatin sensitivity, with a concomitant decrease in previously reported cisplatin resistance signatures, including MYC and oxidative phosphorylation. Conversely, ITGA2 overexpression leads to cisplatin resistance in OS cells. Consistent with these findings, OS patients with high ITGA2 expression showed enhanced gene expression signatures of wound healing and worse prognosis compared to those with low ITGA2 expression. There results suggest that ITGA2 is a potential prognostic marker and therapeutic target in cisplatin-resistant OS.
言語 en
出版者
出版者 The Kindai University Medical Association
言語 en
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ departmental bulletin paper
出版タイプ
出版タイプ AM
出版タイプResource http://purl.org/coar/version/c_ab4af688f83e57aa
ID登録
ID登録 10.15100/0002003779
ID登録タイプ JaLC
収録物識別子
収録物識別子タイプ PISSN
収録物識別子 03866092
収録物識別子
収録物識別子タイプ EISSN
収録物識別子 24327166
書誌情報 en : ACTA MEDICA KINDAI UNIVERSITY

巻 50, 号 2, p. 21-30, 発行日 2025-12
戻る
0
views
See details
Views

Versions

Ver.1 2025-10-27 08:27:40.288455
Show All versions

Share

Share
tweet

Cite as

Other

print

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX
  • ZIP

コミュニティ

確認

確認

確認


Powered by WEKO3


Powered by WEKO3